Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 4:57 pm Purchase |
2024-01-10 | 13G | Elevation Oncology, Inc. ELEV |
Logos Global Management LP | 3,650,000 8.600% |
3,650,000 (New Position) |
Filing History |
| 2024-01-22 4:27 pm Purchase |
2023-06-26 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Logos Global Management LP | 3,469,927 9.900% |
3,469,927 (New Position) |
Filing History |
| 2024-01-02 12:21 pm Purchase |
2023-12-19 | 13G | aTyr Pharma, Inc. ATYR |
Logos Global Management LP | 5,800,000 9.900% |
5,800,000 (New Position) |
Filing History |
| 2023-11-27 5:39 pm Purchase |
2023-09-12 | 13D | Olema Pharmaceuticals, Inc. OLMA |
Logos Global Management LP | 4,266,948 7.800% |
508,130 (+13.52%) |
Filing History |
| 2023-07-18 4:01 pm Purchase |
2023-07-06 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Logos Global Management LP | 254,000 8.100% |
254,000 (New Position) |
Filing History |
| 2023-06-22 1:25 pm Purchase |
2023-06-13 | 13G | Annexon, Inc. ANNX |
Logos Global Management LP | 3,100,000 5.800% |
3,100,000 (New Position) |
Filing History |
| 2023-02-14 4:23 pm Sale |
2022-12-31 | 13G | Allakos Inc. ALLK |
Logos Global Management LP | 5,286,666 6.200% |
-650,000 (-10.95%) |
Filing History |
| 2023-02-14 4:14 pm Purchase |
2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
Logos Global Management LP | 3,900,000 8.100% |
3,900,000 (New Position) |
Filing History |
| 2023-02-14 4:07 pm Sale |
2022-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,435,000 4.800% |
-115,000 (-7.42%) |
Filing History |
| 2023-02-14 3:53 pm Sale |
2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,150,000 4.100% |
-804,392 (-27.23%) |
Filing History |
| 2022-09-28 5:30 pm Purchase |
2022-09-19 | 13G | Allakos Inc. ALLK |
Logos Global Management LP | 5,936,666 7.000% |
5,936,666 (New Position) |
Filing History |
| 2022-05-02 4:02 pm Purchase |
2022-04-20 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 1,550,000 5.200% |
680,000 (+78.16%) |
Filing History |
| 2022-03-31 4:23 pm Purchase |
2022-03-21 | 13D | Design Therapeutics, Inc. DSGN |
Logos Global Management LP | 2,812,501 5.000% |
2,812,501 (New Position) |
Filing History |
| 2022-03-18 5:04 pm Purchase |
2022-03-08 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 265,000 6.900% |
265,000 (New Position) |
Filing History |
| 2022-02-15 08:37 am Sale |
2021-12-31 | 13G | Harpoon Therapeutics, Inc. HARP |
Logos Global Management LP | 150,000 4.600% |
-33,000 (-18.03%) |
Filing History |
| 2022-02-14 4:32 pm Sale |
2021-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Logos Global Management LP | 0 0.000% |
-114,911 (Position Closed) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Logos Global Management LP | 2,954,392 5.700% |
-940,000 (-24.14%) |
Filing History |
| 2022-02-14 3:16 pm Sale |
2021-12-31 | 13G | Bicycle Therapeutics plc BCYC |
Logos Global Management LP | 870,000 3.000% |
-630,000 (-42.00%) |
Filing History |
| 2022-02-14 3:00 pm Sale |
2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR |
Logos Global Management LP | 145,000 3.000% |
-105,000 (-42.00%) |
Filing History |
| 2022-02-14 2:47 pm Sale |
2021-12-31 | 13G | Viridian Therapeutics, Inc. VRDN |
Logos Global Management LP | 0 0.000% |
-1,495,000 (Position Closed) |
Filing History |